VIKING GLOBAL PERFORMANCE LLC's Net Worth

$1.54 Billion

Estimate Recalculated Feb 22, 2024 09:07PM EST

Who is VIKING GLOBAL PERFORMANCE LLC?

VIKING GLOBAL PERFORMANCE LLC has an estimated net worth of $1.54 Billion. This is based on reported shares across multiple companies, which include Adaptive Biotechnologies Corp, Editas Medicine, Inc., Arbutus Biopharma Corp, Myovant Sciences Ltd., Roivant Sciences Ltd., Wayfair Inc., Urovant Sciences Ltd., Axovant Gene Therapies Ltd., FIRST DATA CORP, APi Group Corp, IMCLONE SYSTEMS INC, and BridgeBio Pharma, Inc..

SEC CIK

VIKING GLOBAL PERFORMANCE LLC's CIK is 0001132625

Past Insider Trading and Trends

2019 was VIKING GLOBAL PERFORMANCE LLC's most active year for acquiring shares with 36 total transactions. VIKING GLOBAL PERFORMANCE LLC's most active month to acquire stocks was the month of January. 2016 was VIKING GLOBAL PERFORMANCE LLC's most active year for disposing of shares, totalling 9 transactions. VIKING GLOBAL PERFORMANCE LLC's most active month to dispose stocks was the month of April. 2022 saw VIKING GLOBAL PERFORMANCE LLC paying a total of $200,000,000.00 for 200,000 shares, this is the most they've acquired in one year. In 2020 VIKING GLOBAL PERFORMANCE LLC cashed out on 8,412,899 shares for a total of $302,143,539.29, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Adaptive Biotechnologies Corp (ADPT) Snapshot price: $3.575

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-3.23%
-1.00M
$55.65
-$55,650,000.00
29.99M
Dec 14
Form 4
-7.46%
-2.50M
$49.52
-$123,787,500.00
30.99M
Nov 11
Form 4
-12.79%
-4.91M
$24.98
-$122,706,039.29
33.49M
Jan 28
Form 4
+2,595.20%
36.98M
$20.00
38.41M
Jul 1
Form 3
0
0
No matching records found

FIRST DATA CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
43.5M
43.5M
Apr 13
Form 3
0
0
No matching records found

APi Group Corp (APG) Snapshot price: $34.18

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-18.90%
-6.50M
$31.30
-$203,450,000.00
27.89M
Jan 2
Form 4
0
0
Jan 3
No matching records found

Editas Medicine, Inc. (EDIT) Snapshot price: $7.155

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
5.46M
5.46M
Feb 8 - Feb 8
Form 4
5.46M
5.46M
Feb 8 - Feb 8
Form 3
0
0
No matching records found

Arbutus Biopharma Corp (ABUS) Snapshot price: $2.5

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Form 4
0
0
Jan 12
Form 4
0
0
Oct 16
Form 3
0
0
No matching records found